Jeff Hoschander

Überblick

Jeff Hoschander is a partner in the firm’s Litigation practice. Jeff’s experience is broad, with a primary focus on the representation of corporations in complex commercial, life sciences, securities, and shareholder derivative litigation, as well as regulatory enforcement matters and board committee representations related to corporate governance.

Jeff frequently represents global leaders in the financial industry in high-stakes litigation and enforcement actions. With a distinct perspective attributable to having earned a medical degree, Jeff also specializes in advising clients in the pharmaceutical, biotech and medical device industries on litigation, regulatory and transaction-related matters.

Erfahrung

Representing the special litigation committee of the board of directors of a pharmaceutical company in connection with shareholder derivative litigation
Representing a multinational financial institution in several mortgage-backed securities cases
Representing a pharmaceutical company in a securities class action involving allegations of antitrust violations in connection with the marketing of pharmaceuticals
Representing the underwriters in securities litigation related to the IPO of a bioelectronic medicine company
Obtained dismissal of securities class action related to the cannabis industry
Obtained dismissal for an underwriter in a securities class action arising from an offering by a pharmaceutical company involving allegations regarding disclosures of clinical trial results
Obtained dismissal for underwriters in a securities class action arising from an offering by Insmed Incorporated involving allegations of misrepresentations regarding the regulatory approval prospects for a drug candidate
Obtained dismissal for underwriters in a securities class action arising out of an offering by issuer China Mobile Games & Entertainment Group Limited
Represented directors/officers of a multinational foreign financial institution in connection with a shareholder derivative litigation in which the plaintiff voluntarily dismissed the case while the motion to dismiss was pending
Obtained dismissals for a regional bank in a federal securities fraud class action
Represented several corporations in various investigations by the U.S. Department of Justice, U.S. Securities Exchange Commission and other government agencies
Represented Countrywide in connection with mortgage-backed securities litigation matters
Represented the Securities Industry and Financial Markets Association (SIFMA) as amicus curiae in a securities litigation matter
Represented Bank of America in connection with several securities litigation matters
Represented multinational foreign corporation in connection with cross-border discovery matters
Represented multinational foreign financial institution in connection with investigations and settlement of claims regarding cross-border banking/tax issues by the U.S. Department of Justice, U.S. Securities Exchange Commission and U.S. Internal Revenue Service

Of Note

Publications

Co-author, “Delaware Court of Chancery Holds That Corwin Cleansing Does Not Apply to Claims for Injunctive Relief Related to Alleged Defensive Measures,” The M&A Lawyer, June 2023
Co-author, “Delaware Court of Chancery Dismisses Breach of Contract Claims Against Buyer, Finding Seller Retained Post-Closing Liability Related to Certain Product-Liability Litigations,” The M&A Lawyer, May 2023
Co-author, “Delaware Court of Chancery Grants Plaintiff Attorney's Fees Award Under Corporate Benefit Doctrine for Demand to SPAC Board Leading to Adjusted Voting Structure in Connection with Merger,” The M&A Lawyer, February 2023
Author, “Delaware Court of Chancery Finds Personal Jurisdiction Over LLC “Acting Manager” in Post-Closing Investor Action Challenging Merger with SPAC,” The M&A Lawyer, November/December 2022
Author, “Delaware Supreme Court Reverses Dismissal of a Post-Merger Suit for Alleged Breach of Fiduciary Duty Related to Disclosures on Appraisal Rights,”The M&A Lawyer, August 2022
Author, “Finding That Allegedly Conflicted Acquisition Satisfied Entire Fairness Review, Delaware Court of Chancery Rejects Breach of Fiduciary Duty Claims,” The M&A Lawyer, June 2022
Author, “Eighth Circuit Affirms Dismissal of Merger-Related Derivative Suit for Failure to Plead Demand Excusal,” The M&A Lawyer, May 2022
Author, “Delaware Court of Chancery Rejects Motion to Stay SPAC Breach of Fiduciary Duty Suit Pending Parallel Federal Securities Action,” The M&A Lawyer, April 2022
Co-author, “Delaware Supreme Court Overrules Gentile Carve-out, Holding an Improper Transfer of Economic Value & Voting Power to a Controlling Stockholder Through an Equity Overpayment is a Derivative Claim,” Thomson Reuters, December 2021
Co-author, “New York Appellate Court Holds That Claims for Breach of RMBS Representations and Warranties Accrue on Issuance,” Bank and Corporate Governance Law Reporter Interim Report, January 16, 2014
Co-author, “Supreme Court Rules that Class Was Not Properly Certified Because Plaintiffs Did Not Establish that Damages Could Be Measured on a Class-wide Basis,” Securities Reform Act Litigation Reporter, Vol. 35 Nos. 1 & 2, April & May 2013